The Trump administration may reduce the 10-year exclusivity period brand-name drugmakers are given before generic competition is allowed, people familiar with the matter told The Wall Street Journal.

Let's say you're a company looking to get acquired, and you've been approached by a suitor. Maybe several, if you're lucky. Before the mayhem of the bidding war ensues, the buyer you like says, "We ...

VANCOUVER, BC, Aug. 9, 2023 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reports that, further to the Company's news release of May 15, 2023, ...

On 4 June 2025, the Council of the EU adopted its position on the EU Pharma Law Package legislative proposal to revise the EU’s general pharmaceutical legislation. The Council, consisting of all the ...

Forbes contributors publish independent expert analyses and insights. Providing tools and resources to start, grow and manage your business. In acquisitions of privately held companies, an acquisition ...

BELLEVUE, Wash., Dec. 2, 2025 /PRNewswire/ -- OSR Holdings, Inc. (OSRH) today provided an update regarding the previously announced non-binding term sheet between its subsidiary, Vaximm AG, and BCM ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Arrowhead Pharmaceuticals, Inc. (ARWR) has disclosed a new risk, in the Regulation category. Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with ...

(Reuters) -Australia's Insignia Financial said on Thursday that it has extended the exclusivity period by four weeks for both its bidders, Bain Capital and CC Capital Partners, to consider their ...

Santos has extended its exclusivity period with the XRG Consortium as discussions continue over a proposed $18.7bn (A$28.74bn) acquisition. In a statement, the Australian gas company said the ...